May 16, 2018

Milbank Advises ECM-Fund GEP IV on the Sale of its Majority Shareholding in MediFox to HgCapital

Share

The international law firm Milbank LLP has advised German Equity Partners IV (GEP IV), a fund managed by the private equity firm ECM Equity Capital Management (ECM), on the sale of its majority shareholding in Medifox to HgCapital (Hg). The fund, administered by ECM Equity Capital Management GmbH (ECM), now relinquishes its interest in MediFox to Hg, an international investor, who specializes in the software sector. The transaction is submitted for the approval of the competent public authorities.

ECM is an independent private equity firm located in Frankfurt. ECM is and has been the manager and advisor of the private equity funds German Equity Partners I-V with an equity volume of approx. 1 billion Euros. The investment strategy is to acquire equity interests in established and well-positioned mid-size companies.

MediFox is a leading provider of software solutions for more than 6,000 outpatient nursing services, retirement homes and treatment services in Germany. MediFox software solutions supports treatment services in the area of resource and route planning as well as care record. The company´s headquarter is located in Hildesheim and employs a workforce of about 265 employees.

A Milbank team led by partner Michael Bernhardt comprehensively advised GEP IV on the transaction as lead counsel on corporate, finance and tax law.

Advisor to GEP IV: Milbank LLP

Michael Bernhardt (lead), Sebastian Dexheimer, Jörg Neubauer (all Corporate/M&A, Frankfurt), Matthias Schell, Moritz Philipp (all Tax, Munich), Mathias Eisen, Thomas Ingenhoven, Nikolas Koutsós, Thomas Möller, Gerrit Merkel, Katja Lehr (all Finance, Frankfurt), Alexander Rinne, Vanessa van Weelden (both Competition, Munich)